| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |